Literature DB >> 30401536

cAMP regulation of protein phosphatases PP1 and PP2A in brain.

Shannon N Leslie1, Angus C Nairn2.   

Abstract

Normal functioning of the brain is dependent upon a complex web of communication between numerous cell types. Within neuronal networks, the faithful transmission of information between neurons relies on an equally complex organization of inter- and intra-cellular signaling systems that act to modulate protein activity. In particular, post-translational modifications (PTMs) are responsible for regulating protein activity in response to neurochemical signaling. The key second messenger, cyclic adenosine 3',5'-monophosphate (cAMP), regulates one of the most ubiquitous and influential PTMs, phosphorylation. While cAMP is canonically viewed as regulating the addition of phosphate groups through its activation of cAMP-dependent protein kinases, it plays an equally critical role in regulating removal of phosphate through indirect control of protein phosphatase activity. This dichotomy of regulation by cAMP places it as one of the key regulators of protein activity in response to neuronal signal transduction throughout the brain. In this review we focus on the role of cAMP in regulation of the serine/threonine phosphatases protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) and the relevance of control of PP1 and PP2A to regulation of brain function and behavior.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Brain; PKA; PP1; PP2A; Striatum; cAMP

Mesh:

Substances:

Year:  2018        PMID: 30401536      PMCID: PMC6433392          DOI: 10.1016/j.bbamcr.2018.09.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  132 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

Review 2.  Coordination of Protein Phosphorylation and Dephosphorylation in Synaptic Plasticity.

Authors:  Kevin M Woolfrey; Mark L Dell'Acqua
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

Review 3.  cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes.

Authors:  S S Taylor; J A Buechler; W Yonemoto
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 4.  Tailoring cAMP-signalling responses through isoform multiplicity.

Authors:  M D Houslay; G Milligan
Journal:  Trends Biochem Sci       Date:  1997-06       Impact factor: 13.807

Review 5.  Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates.

Authors:  David L Brautigan; Shirish Shenolikar
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

6.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

Authors:  H C Hemmings; P Greengard; H Y Tung; P Cohen
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

Review 7.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis.

Authors:  Satoru Mochida; Sarah L Maslen; Mark Skehel; Tim Hunt
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

9.  Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells.

Authors:  J Christoffersen; E B Smeland; T Stokke; K Taskén; K B Andersson; H K Blomhoff
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

10.  Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis.

Authors:  Nikoleta G Tsvetanova; Mark von Zastrow
Journal:  Nat Chem Biol       Date:  2014-11-02       Impact factor: 15.040

View more
  10 in total

1.  Chronic alcohol disrupts hypothalamic responses to stress by modifying CRF and NMDA receptor function.

Authors:  Vincent N Marty; Yatendra Mulpuri; Joseph J Munier; Igor Spigelman
Journal:  Neuropharmacology       Date:  2020-02-12       Impact factor: 5.250

2.  Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment.

Authors:  Junjiro Yoshida; Tomokazu Ohishi; Hikaru Abe; Shun-Ichi Ohba; Hiroyuki Inoue; Ihomi Usami; Masahide Amemiya; Raphael Oriez; Chiharu Sakashita; Shingo Dan; Minoru Sugawara; Tokuichi Kawaguchi; Junko Ueno; Yuko Asano; Ami Ikeda; Manabu Takamatsu; Gulanbar Amori; Yasumitsu Kondoh; Kaori Honda; Hiroyuki Osada; Tetsuo Noda; Takumi Watanabe; Takao Shimizu; Masakatsu Shibasaki; Manabu Kawada
Journal:  iScience       Date:  2021-11-25

3.  Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension.

Authors:  Dan Li; Kun Liu; Harvey Davis; Calum Robertson; Oliver C Neely; Adib Tarafdar; Ni Li; Konstantinos Lefkimmiatis; Manuela Zaccolo; David J Paterson
Journal:  Hypertension       Date:  2022-05-04       Impact factor: 9.897

4.  Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation.

Authors:  Kristie Stefanoska; Mehul Gajwani; Amanda R P Tan; Holly I Ahel; Prita R Asih; Alexander Volkerling; Anne Poljak; Arne Ittner
Journal:  Sci Adv       Date:  2022-07-06       Impact factor: 14.957

Review 5.  Phosphoproteomic Analysis as an Approach for Understanding Molecular Mechanisms of cAMP-Dependent Actions.

Authors:  Joseph A Beavo; Martin Golkowski; Masami Shimizu-Albergine; Michael-Claude Beltejar; Karin E Bornfeldt; Shao-En Ong
Journal:  Mol Pharmacol       Date:  2021-02-11       Impact factor: 4.054

6.  A phosphatase-centric mechanism drives stress signaling response.

Authors:  David Maria Hollenstein; Gabriela Gérecová; Natalie Romanov; Jessica Ferrari; Jiri Veis; Marion Janschitz; Reinhard Beyer; Christoph Schüller; Egon Ogris; Markus Hartl; Gustav Ammerer; Wolfgang Reiter
Journal:  EMBO Rep       Date:  2021-09-24       Impact factor: 8.807

7.  The CaMKII/MLC1 Axis Confers Ca2+-Dependence to Volume-Regulated Anion Channels (VRAC) in Astrocytes.

Authors:  Maria Stefania Brignone; Angela Lanciotti; Antonio Michelucci; Cinzia Mallozzi; Serena Camerini; Luigi Catacuzzeno; Luigi Sforna; Martino Caramia; Maria Cristina D'Adamo; Marina Ceccarini; Paola Molinari; Pompeo Macioce; Gianfranco Macchia; Tamara Corinna Petrucci; Mauro Pessia; Sergio Visentin; Elena Ambrosini
Journal:  Cells       Date:  2022-08-26       Impact factor: 7.666

8.  Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy.

Authors:  Egidio Spinelli; Kyle R Christensen; Emily Bryant; Amy Schneider; Jennifer Rakotomamonjy; Alison M Muir; Jessica Giannelli; Rebecca O Littlejohn; Elizabeth R Roeder; Berkley Schmidt; William G Wilson; Elysa J Marco; Kazuhiro Iwama; Satoko Kumada; Tiziana Pisano; Carmen Barba; Annalisa Vetro; Eva H Brilstra; Richard H van Jaarsveld; Naomichi Matsumoto; Hadassa Goldberg-Stern; Patrick W Carney; P Ian Andrews; Christelle M El Achkar; Sam Berkovic; Lance H Rodan; Kirsty McWalter; Renzo Guerrini; Ingrid E Scheffer; Heather C Mefford; Simone Mandelstam; Linda Laux; John J Millichap; Alicia Guemez-Gamboa; Angus C Nairn; Gemma L Carvill
Journal:  Ann Neurol       Date:  2021-07-13       Impact factor: 11.274

9.  The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.

Authors:  Elena J Kumm; Oliver Pagel; Stepan Gambaryan; Ulrich Walter; René P Zahedi; Albert Smolenski; Kerstin Jurk
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

10.  RNA-Seq and differential gene expression analysis in Temora stylifera copepod females with contrasting non-feeding nauplii survival rates: an environmental transcriptomics study.

Authors:  Ennio Russo; Chiara Lauritano; Giuliana d'Ippolito; Angelo Fontana; Diana Sarno; Eric von Elert; Adrianna Ianora; Ylenia Carotenuto
Journal:  BMC Genomics       Date:  2020-10-06       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.